| AATSX | FSSNX | AATSX / FSSNX | |
| Total Expense Ratio | 1.01 | 0.03 | 4,040% |
| Annual Report Gross Expense Ratio | 1.21 | 0.03 | 4,840% |
| Fund Existence | 10 years | 14 years | - |
| Gain YTD | -3.236 | 6.322 | -51% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1500000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 205M | 29B | 1% |
| Annual Yield % from dividends | 0.37 | 0.80 | 46% |
| Returns for 1 year | -11.39 | 3.04 | -374% |
| Returns for 3 years | 22.67 | 32.74 | 69% |
| Returns for 5 years | 18.50 | 37.23 | 50% |
| Returns for 10 years | 58.88 | 96.31 | 61% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| NWALX | 36.97 | 0.08 | +0.22% |
| Nationwide BNY Mellon Dyn US Eq Inc A | |||
| STVTX | 10.45 | N/A | N/A |
| Virtus Ceredex Large-Cap Value Equity I | |||
| KTCSX | 48.36 | N/A | N/A |
| DWS Science and Technology S | |||
| WCMLX | 13.04 | N/A | N/A |
| WCM Small Cap Growth Institutional | |||
| MEMGX | 42.59 | -0.42 | -0.98% |
| MFS Emerging Markets Equity R3 | |||